Skip to main content
  • ILLUMENATE Shows Favorable Outcomes at 4 Years with Stellarex Drug-Coated Balloon

    At 4 years, the Stellarex paclitaxel drug-coated balloon (DCB) demonstrated favorable long-term safety and efficacy outcomes supporting its use in treating femoropopliteal lesions, according to study results presented Sunday at the TCT Connect virtual conference.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details